Entera Bio Ltd. (ENTX) vs Health Catalyst, Inc. (HCAT)
A side-by-side comparison of Entera Bio Ltd. and Health Catalyst, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ENTX
Entera Bio Ltd.
$2.57HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
HCAT
Health Catalyst, Inc.
$1.78HealthcareDelayed quote: Oct 6, 2026, 3:34 PM EDT
Total return — ENTX vs HCAT
growth of $100 · dividends reinvested · last 7yENTX -30.1% (-5.0%/yr)HCAT -95.5% (-35.8%/yr)ENTX compounded faster over this window
Log scale — wide-divergence pair
ENTX HCAT
ENTX vs HCAT: by the numbers
- •HCAT is the larger company ($132M vs $126M market cap).
- •Both run net losses; HCAT's is the smaller (-90.61% vs -27235.71% net margin).
Metrics side by side
Valuation
| Metric | ENTX | HCAT |
|---|---|---|
| P/S ratio | N/A | 0.45 |
| P/B ratio | 17.40 | 1.30 |
| EV / EBITDA | N/A | 74.61 |
| FCF yield | N/A | 9.93% |
Profitability
| Metric | ENTX | HCAT |
|---|---|---|
| Gross margin | 0.00% | 33.47% |
| Operating margin | -27450.00% | -11.60% |
| Net margin | -27235.71% | -90.61% |
| ROE | -234.42% | -262.64% |
| ROIC | -82.87% | -21.42% |
Growth (annualized)
| Metric | ENTX | HCAT |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 6.24% |
| Total return CAGR (5Y) | -10.57% | -48.35% |
Frequently asked
- How have ENTX and HCAT total returns compared?
- Over the past 5 years, ENTX delivered -10.57% and HCAT delivered -48.35% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Entera Bio ROEHealth Catalyst ROEEntera Bio operating marginHealth Catalyst operating marginEntera Bio revenue growthHealth Catalyst revenue growthEntera Bio free cash flowHealth Catalyst free cash flow
Entera Bio & Health Catalyst appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.